Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Blood Advances
|
June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
Gustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Bone Marrow Transplantation
|
February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
Magdalena Corona, Andrew Ip, Samantha Brown, et al.
Blood Cancer Journal
|
April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
Alejandro Luna, Sean M Devlin, Kai Rejeski, et al.
International Journal of Neonatal Screening
|
August 23, 2022
Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
Margherita Ruoppolo, Sabrina Malvagia, Sara Boenzi, et al.
Journal of Inherited Metabolic Disease
|
February 12, 2019
Newborn screening for homocystinurias: Recent recommendations versus current practice
Rebecca Keller, Petr Chrastina, Markéta Pavlíková, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 7, 2012
Enhanced interpretation of newborn screening results without analyte cutoff values
Gregg Marquardt, Robert Currier, David M S McHugh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 18, 2011
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project
David M S McHugh, Cynthia A Cameron, Jose E Abdenur, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Blood Advances
|
June 11, 2024
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
Gustav Y Cederquist, Javin Schefflein, Sean M Devlin, et al.
Hemasphere
|
December 1, 2025
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma
Efrat Luttwak, David Nemirovsky, Sean M Devlin, et al.
Bone Marrow Transplantation
|
February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
Magdalena Corona, Andrew Ip, Samantha Brown, et al.
Blood Cancer Journal
|
April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
Alejandro Luna, Sean M Devlin, Kai Rejeski, et al.
International Journal of Neonatal Screening
|
August 23, 2022
Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
Margherita Ruoppolo, Sabrina Malvagia, Sara Boenzi, et al.
Journal of Inherited Metabolic Disease
|
February 12, 2019
Newborn screening for homocystinurias: Recent recommendations versus current practice
Rebecca Keller, Petr Chrastina, Markéta Pavlíková, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 7, 2012
Enhanced interpretation of newborn screening results without analyte cutoff values
Gregg Marquardt, Robert Currier, David M S McHugh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 18, 2011
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project
David M S McHugh, Cynthia A Cameron, Jose E Abdenur, et al.
Page
of 8